BD is one of the top suppliers of prefilled syringes to the pharma industry, with more than a billion UltraSafePlus devices used in around 40 different products since it was first launched in 2010.

The US multinational has been Drogheda for 60 years and in 2021 it opened a new facility in the area as part of a €62m investment to expand the company’s production of BD PosiFlush syringes.

BD and its management have denied any wrongdoing ... due to compatibility issues with Cardinal Health's (CAH) Monoject ...